Tucatinib combined with trastuzumab and capecitabine improved brain metastasis survival in a recent clinical trial.…
MDNewsline DailyNovember 28, 2023
Atezolizumab therapy for advanced or metastatic triple-negative breast cancer (TNBC) was found to have a…
MDNewsline DailyNovember 28, 2023
A recent survey study concluded that to encourage metastatic breast cancer patients to exercise, individualized,…
MDNewsline DailyNovember 28, 2023
Trastuzumab deruxtecan significantly improved overall survival compared to trastuzumab emtansine in a multi-center phase 3…
MDNewsline DailyNovember 28, 2023
Triple-negative breast cancer patients treated with immune checkpoint inhibitors may experience a greater antitumoral immune…
MDNewsline DailyNovember 28, 2023
Elacestrant improves progression-free survival in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast…
MDNewsline DailyNovember 28, 2023
Racial disparities in curative intent surgery, endocrine therapy, and treatment-related adverse effects were seen among…
MDNewsline DailyNovember 28, 2023
Oral selective estrogen receptor degraders are effective in the estrogen receptor 1 mutation subgroup of…
MDNewsline DailyNovember 28, 2023
Obesity is a risk factor for cancer recurrence in resected hormone-sensitive breast cancer patients undergoing…
MDNewsline DailyNovember 28, 2023